Controversial on-track pharmacies being promoted by Stronach read blog
Thoroughbred industry stakeholders in West Virginia will meet May 6 to consider changes in the state's racing rules, including a few related to the National Uniform Medication Program.
Florida and Arkansas illustrate the challenges in obtaining uniformity. read blog
Ding-dong data: Uniformity doesn't seem to be a priority for racetrack past-performance information. read blog
The industry is still short of the goal of uniformity from state to state read blog
- By Tom LaMarra
Though studies have been completed to determine threshold levels for almost 20 therapeutic medications, it doesn't mean the industry will know for certain whether the drugs can impact equine performance.
The National Horsemen's Benevolent and Protective Association has adopted a position paper on medication and drug-testing that says any changes in policies in each jurisdiction should be enacted only after there is scientific evidence specific therapeutic drugs shouldn't be used in racehorses.
The Thoroughbred Corp.'s Kafwain was disqualified from his second-place finish in the March 9 Louisiana Derby at Fair Grounds because he raced with an excessive amount of the bronchodilator clenbuterol. Trainer Bob Baffert did not appeal so Kafwain could make his next racing engagement, but he has called for uniformity in medication rules.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
The chairman of the Kentucky Racing Commission said Sept. 13 he hopes a revised race-day medication policy for the Bluegrass state becomes a model for the rest of the country as it pushes toward uniformity in racehorse medication and drug testing.
Setting a national policy for racehorse medication is a vital step for the sport's long-term health, a top industry executive told the 2002 Harness Racing Congress in Las Vegas, Nev., Feb. 20.
The racing industry's quest for uniformity in medication and drug testing continued Wednesday with a lively panel discussion on the issue at the University of Arizona Symposium on Racing in Tucson. Meanwhile, the jury is out as to whether there will be considerable change in Kentucky, a major racing state where officials appear split on the issue.
Most Popular Stories
- Final Call for Taylors of Seattle Slew Fame
- New York Sanctions Mott for Drug Overages
- NYRA Unveils 10-Race Claiming Series
- Washington Owner/Breeder Paxton Dead at 76
- OBS Expects Solid Start for Auction Season
- Untapable, Tapiture Drill for Asmussen
- Five Tie for Fastest 3 Furlongs at OBS Show
- NY Investigation of Asmussen Case Completed
- 'Chrome' Set for San Antonio, Bayern Doubtful
- Main Sequence Works at Palm Meadows